

Scientists created a breakthrough mRNA treatment that shields insulin-producing cells from immune attacks, potentially preventing type 1 diabetes before it starts.

Early tests in mice show the nanoparticle therapy successfully reached target cells and delayed disease progression.

Want to know more?